Skip to Main Content

Paper Details

Discordance of HER2 Expression and/or Amplification on Repeat Testing.
Mol Cancer Ther
2
2023
HER2, HER2 2+, HER2 2+ tumors, Patients, archival, cancer, cancers, metastatic solid tumors, patients, solid tumors, tumors
Author NameAffiliation
Shubham PantThe University of Texas MD Anderson Cancer Center
Shubham PantThe University of Texas MD Anderson Cancer Center
Michael F PressDepartment of Pathology and Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 5

Datasets

Release 1.2